Media

Corgentech to Webcast Presentations From Three Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., March 24, 2005 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK), a biotechnology company, today announced that John P. McLaughlin, the company's president and chief executive officer, has been invited to present at three upcoming investor conferences. Each of the presentations will be webcast live and will also have replays that will be accessible through the Corgentech website. Following is the schedule of presentations:

-- April 1, 2005, 10:45 a.m. EST:  Lehman Brothers Eighth Annual Global
       Healthcare Conference
    -- April 5, 2005, 1:15 p.m. EST:  CIBC Biotech & Specialty Pharmaceuticals
       Conference
    -- April 7, 2005, 1:50 p.m. EST:  BioCentury Future Leaders in the Biotech
       Industry Conference

To access the live webcast or the subsequent archived recording, log on to www.corgentech.com and go to the Investors page, and click on Webcasts. Please connect to Corgentech's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

About Corgentech

Corgentech is a biopharmaceutical company engaged in the discovery, development and commercialization of a new class of therapeutics called transcription factor decoys, or TF decoys. The company is creating a pipeline of novel therapeutics based on its proprietary TF decoy technology, focused initially on the treatment of cardiovascular disease, inflammatory disease and cancer. For more information on the company and its technologies, visit www.corgentech.com.

SOURCE Corgentech Inc.

Jennifer Cook Williams, Senior Director, Investor Relations, of Corgentech Inc.,
+1-650-624-9600, or [email protected]

http://www.prnewswire.com

News Provided by COMTEX